Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Retained Earnings (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Retained Earnings for 2 consecutive years, with -$34.7 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings fell 33.22% to -$34.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$34.7 million through Dec 2025, down 33.22% year-over-year, with the annual reading at -$34.7 million for FY2025, 33.22% down from the prior year.
  • Retained Earnings for Q4 2025 was -$34.7 million at Jupiter Neurosciences, down from -$32.1 million in the prior quarter.
  • The five-year high for Retained Earnings was -$24.5 million in Q3 2024, with the low at -$34.7 million in Q4 2025.